|
|
|
Volumn 52, Issue RR-4, 2003, Pages 1-28
|
|
Smallpox vaccination and adverse reactions. Guidance for clinicians.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIVIRUS AGENT;
CIDOFOVIR;
CYTOSINE;
DRUG DERIVATIVE;
IMMUNOGLOBULIN;
NEW DRUG;
ORGANOPHOSPHORUS COMPOUND;
PHOSPHONIC ACID DERIVATIVE;
SMALLPOX VACCINE;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
BULLOUS SKIN DISEASE;
CENTRAL NERVOUS SYSTEM DISEASE;
CHILD;
CROSS INFECTION;
DERMATITIS;
DISEASE TRANSMISSION;
DRUG CONTRAINDICATION;
DRUG SURVEILLANCE PROGRAM;
EYE INFECTION;
FEMALE;
FETUS DISEASE;
HUMAN;
HYPERSENSITIVITY;
IMMUNE DEFICIENCY;
IMMUNOLOGICAL PROCEDURES;
IMMUNOLOGY;
INFANT;
INFECTION CONTROL;
MALE;
MIDDLE AGED;
PRACTICE GUIDELINE;
PREGNANCY;
PRESCHOOL CHILD;
RISK FACTOR;
VACCINATION;
VACCINIA;
ADOLESCENT;
ADULT;
ADVERSE DRUG REACTION REPORTING SYSTEMS;
AGED;
ANTIVIRAL AGENTS;
CENTRAL NERVOUS SYSTEM DISEASES;
CHILD;
CHILD, PRESCHOOL;
CROSS INFECTION;
CYTOSINE;
DISEASE TRANSMISSION, HORIZONTAL;
DISEASE TRANSMISSION, VERTICAL;
DRUGS, INVESTIGATIONAL;
EYE INFECTIONS;
FEMALE;
FETAL DISEASES;
HUMANS;
HYPERSENSITIVITY;
IMMUNOCOMPROMISED HOST;
IMMUNOGLOBULINS, INTRAVENOUS;
IMMUNOLOGIC TESTS;
INFANT;
INFECTION CONTROL;
MALE;
MIDDLE AGED;
ORGANOPHOSPHORUS COMPOUNDS;
PHOSPHONIC ACIDS;
PREGNANCY;
RISK FACTORS;
SKIN DISEASES, ECZEMATOUS;
SKIN DISEASES, VESICULOBULLOUS;
SMALLPOX VACCINE;
VACCINATION;
VACCINIA;
|
|
EID: 0037458734
PISSN: 10575987
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (261)
|
|
References (0)
|
